Stocks
BioXcel (BTAI) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -41 925% | -41 969% | -11 987% | -1 949% | -7 695% | -8 511% | ||
| Changes by years, y/y, % | -45pp | +29 982pp | +10 038pp | -5 747pp | -43.2% | ||||
BioXcel. EBITDA margin, %
BioXcel. EBITDA margin, changes, pp
BioXcel (BTAI) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA margin, % | ? | -1 844% | -1 896% | -12 408% | -27 003% | -3 946% | -8 511% | |
| Changes by years, y/y, % | +3 141pp | +2 074pp | -11 999pp | -22 432pp | -2 101pp | |||
| Changes by quarters, q/q, % | +2 727pp | -52pp | -10 512pp | -14 595pp | +23 057pp | |||
